StockNews.com initiated coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Adaptimmune Therapeutics Trading Up 14.9 % Shares of NASDAQ:ADAP opened at $0.79 on Friday. Adaptimmune Therapeutics has a 1 year low of […]
StockNews.com initiated coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a report published on Wednesday. The brokerage issued a hold rating on the biotechnology company’s stock. ADAP has been the subject of several other reports. Barclays decreased their price target on shares of Adaptimmune Therapeutics from $2.00 to $1.00 and set an […]
Rock Springs Capital Management LP raised its holdings in Immatics (NASDAQ:IMTX – Free Report) by 0.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,536,144 shares of the company’s stock after purchasing an additional 22,221 shares during the quarter. Rock Springs Capital Management […]
Rock Springs Capital Management LP lowered its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 41.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 401,624 shares of the company’s stock after selling 283,999 shares during the quarter. Rock Springs […]